CLINICAL AND SUBCLINICAL CHARACTERISTICS OF PATIENTS WITH LONG COVID AT RESPIRATORY OUTPATIENT CLINICS OF TAM ANH HOSPITAL

Văn Ngân Nguyễn 1,, Thu Phương Phan 1, Quý Châu Ngô 2, Thị Hạnh Chu 2
1 HMU
2 Tam anh hospital

Main Article Content

Abstract

Background: COVID-19 is a widespread pandemic that has led to a dramatic loss of human life worldwide and presents an unprecedented challenge to public health. Some patients who recover from COVID-19 develop persistent or new symptoms known as “long COVID”. Long COVID is reported to affect a considerable portion of COVID-19 recoverees, which is estimated to be at 10-30%, and symptoms may persist for longer than 1 year. There is fewer clinical and subclinical studies of patients with long COVID-19 in Viet Nam. Therefore, we conducted this study to evaluate some clinical and subclinical characteristics of patients with long COVID-19. Objective: Describe clinical features and paraclinical characteristics in patients with long COVID-19. Subjects and Methods: A cross-sectional study was carried 172 patients with long COVID-19 managed at Tam Anh hospital from February, 2022 to october, 2022. Results: The common symptoms: Fatigue (57%), shortness of breath (51,2%), dry cough (43,6%), chest pain (27,3%), insomnia (25%), and attention disorder or memory impairment (25,3%); Blood tests: AST > 40 U/l (2,9%), ALT > 40 U/l (4,1%), CRP > 0,5 mg/dl (10,1%), Ferritin >300 ng/ml (19,6%), D-dimer > 0,5 µg FEU/ml (9,9%). Chest X-ray: (n=152): bronchial wall thickening (13,2%), consolidation (3,9%), ground-glass opacity (3,9%), nodule (2,6%); Chest CT (n=56): Linear opacity (37,5%), bronchiectasis and bronchial wall thickening (33,9%), ground-glass opacity (21,4%), nodule (19,6%), consolidation (10,7%), pulmonary fibrosis (8,9%); Spirometry: signs of restrictive ventilatory disorder (18,02%), obstructive ventilatory disorder (5,81%); 6 minute walk test (n = 93): Decline in walking distance (87,1%), 6MWD mean: 468,05 ± 61,12 (m). Conclusion: Long COVID-19 is multiorgan syndrome caused persistent health problems. Common symptoms: Fatigue, shortness of breath, shortness of breath, Decline in walking distance after the 6-minute walking test. Long-term monitoring and management of patients with long COVID-19 is required.

Article Details

References

1. National Institute for Health and Care Excellence: Clinical Guidelines. In: COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE). Copyright © NICE 2020.; 2020.
2. Hastie CE, Lowe DJ, McAuley A, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nature Communications. 2022;13(1):5663.
3. Taquet M, Dercon Q. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. 2021;18(9):e1003773.
4. Arnold DT, Hamilton FW, Milne A, et al. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. 2021;76(4):399-401.
5. Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. The Journal of infection. 2020;81(6):e4-e6.
6. Anastasio F, Barbuto S, Scarnecchia E, et al. Medium-term impact of COVID-19 on pulmonary function, functional capacity and quality of life. The European respiratory journal. 2021;58(3).
7. Trinkmann F, Müller M, Reif A, Kahn N. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection. 2021;57(2).
8. González J, Benítez ID, Carmona P, et al. Pulmonary Function and Radiologic Features in Survivors of Critical COVID-19: A 3-Month Prospective Cohort. Chest. 2021;160(1):187-198.